Norway’s First Interest-Rate Hike Isn’t Far Off: Decision Guide
(Bloomberg) -- Discover what's driving the global economy and what it means for policy makers, businesses, investors and you with The New Economy Daily. Sign up here
The prospect of a Norwegian interest-rate increase as soon as September is likely to be the key focus of the central-bank decision there this week.
While all economists in a Bloomberg survey expect the Norges Bank to keep its key deposit at zero for an eighth consecutive meeting, the possibility that it might soon become the first developed nation to start a hiking cycle is drawing heightened scrutiny.
Norway has the lowest real interest rates -- the difference between its inflation and policy rates -- among holders of the world's major currencies, a backdrop that could embolden policy makers to raise borrowing costs to cool the booming housing market.
Helping to determine that will be the central bank's assessment of progress in vaccinations, and how it will affect reopening the Nordic region's richest economy. Officials' most recent guidance suggested equal odds of a hike in September or December, and the latest data haven't clearly tipped the scales either way.
What Bloomberg Economics Says...
“The combination of vaccination progress and rising house prices could nudge the Norges Bank to add a hawkish tone to the press release that will accompany its monetary policy decision. Still, we don't expect the bank to promise earlier hikes as there's some uncertainty about the trajectory for growth.”
--Johanna Jeansson, economist. Click here for the full preview
Norway's underlying inflation was in line with central bank forecasts in March, while economic expansion in January and February was weaker than anticipated.
House prices have been rising at their fastest annual pace since 2016, though data published on Wednesday showed a slowdown in April, with a second monthly decline in Oslo. That might help soothe financial stability concerns at the central bank.
Vaccine efforts have been disrupted by Norway's decision in March to suspend use of AstraZeneca Plc jabs, based on the judgment that associated blood-clot risks are too great. Next week, a committee will rule on how Norway could be affected by a decision to permanently rule out immunizations using Astra's and Johnson & Johnson's shots.
Still, delivery forecasts for other vaccines have been raised, suggesting the nation can still reach its present inoculation timeline.
| Read More... |
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.